Handelsbanken Fonder’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$476K Buy
81,900
+16,400
+25% +$109K ﹤0.01% 1381
2026
Q1
$475K Buy
65,500
+10,800
+20% +$141K ﹤0.01% 1314
2025
Q4
$930K Buy
54,700
+3,900
+8% +$39.6K ﹤0.01% 1063
2025
Q3
$372K Hold
50,800
﹤0.01% 1370
2025
Q2
$330K Buy
+50,800
New +$335K ﹤0.01% 1398
2025
Q1
Sell
-50,800
Closed -$628K 1544
2024
Q4
$628K Buy
+50,800
New +$678K ﹤0.01% 1197

Other funds holding WVE

Handelsbanken Fonder's WVE Position: Q2 2026 in Review

Handelsbanken Fonder increased its Wave Life Sciences (WVE) stake by 25% in Q2 2026, buying an estimated $109K and bringing the position to 81,900 shares worth $476K. The position accounts for ﹤0.01% of the portfolio, ranked #1381.

Handelsbanken Fonder first reported a position in WVE in Q4 2024 and has held it in 6 quarters since. The position peaked at $930K in Q4 2025. 30 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Handelsbanken Fonder held 81,900 shares of Wave Life Sciences worth $476K as of Q2 2026.
  • Handelsbanken Fonder bought 16,400 Wave Life Sciences shares in Q2 2026, an estimated $109K.
  • Wave Life Sciences made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1381 holding.
  • Handelsbanken Fonder first reported a position in Wave Life Sciences in Q4 2024 and has held it in 6 quarters since.
  • Handelsbanken Fonder's Wave Life Sciences position peaked at $930K in Q4 2025.
  • 30 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.